ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 315

$978K Total Retail Price of All Prescriptions

Rank: 14 out of 315

747 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 747 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 747 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 12,535 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
ATORVASTATIN CALCIUM 665 651 1 5
AMLODIPINE BESYLATE 631 586 2 2
SIMVASTATIN 513 472 3 1
LEVOTHYROXINE SODIUM 338 333 4 6
LOSARTAN POTASSIUM 335 327 5 4
METFORMIN HCL 325 297 6 7
LISINOPRIL 319 294 7 3
FUROSEMIDE 314 313 8 15
LOSARTAN-HYDROCHLOROTHIAZIDE 303 286 9 17
HYDROCHLOROTHIAZIDE 223 205 10 16
METOPROLOL SUCCINATE 215 201 11 13
PRAVASTATIN SODIUM 212 212 12 10
ACTOS 171 159 13 78
ALLOPURINOL 170 166 14 14
PANTOPRAZOLE SODIUM 167 162 15 35
ATENOLOL 165 155 16 11
GEMFIBROZIL 162 155 17 70
PREDNISONE 157 152 18 41
AMLODIPINE BESYLATE-BENAZEPRIL 152 147 19 26
LIPITOR 151 151 20 44
TAMSULOSIN HCL 147 147 21 21
DONEPEZIL HCL 136 136 22 28
OMEPRAZOLE 128 127 23 9
AMLODIPINE-ATORVASTATIN 128 119 10 23 118
LABETALOL HCL 122 117 25 125
GLYBURIDE 120 101 R 26 49
METOPROLOL TARTRATE 112 109 27 18
LOVASTATIN 103 103 28 8
ALENDRONATE SODIUM 99 99 29 12
EXFORGE 97 97 30 107
ZOLPIDEM TARTRATE 97 97 30 29
NADOLOL 94 91 32 181
CARVEDILOL 91 89 33 22
NAMENDA 89 89 34 38
DIOVAN 89 89 34 27
HYDROCODONE-ACETAMINOPHEN 89 89 S3 34 19
POTASSIUM CHLORIDE 87 87 37 36
GLIPIZIDE 87 87 37 30
IRBESARTAN 86 73 39 66
GLIPIZIDE ER 86 84 39 55
DILTIAZEM 24HR ER 84 84 41 90
WARFARIN SODIUM 80 80 42 20
CLOPIDOGREL 79 79 43 25
DIOVAN HCT 79 79 43 56
FAMOTIDINE 77 77 45 75
ZETIA 72 72 46 84
FINASTERIDE 72 72 46 60
FOLIC ACID 70 70 48 152
FENOFIBRATE 70 58 48 43
FELODIPINE ER 68 68 50 23
METFORMIN HCL ER 67 66 51 33
PIOGLITAZONE HCL 64 64 R 52 185
DIGOXIN 64 64 52 45
VERAPAMIL ER 64 58 52 94
DEXAMETHASONE 63 61 55 241
GLYBURIDE-METFORMIN HCL 62 62 R 56 87
EVISTA 62 62 56 48
CIPROFLOXACIN HCL 60 56 58 58
AZITHROMYCIN 60 59 58 39
KLOR-CON 10 58 58 60 183
DILTIAZEM ER 56 56 61 151
PLAVIX 56 56 61 40
ALBUTEROL SULFATE 55 54 63 319
CELEBREX 55 55 63 34
AVAPRO 54 51 65 138
SYNTHROID 54 54 65 51
METHYLPREDNISOLONE 53 49 67 222
AVODART 52 51 68 113
ACTONEL 50 47 69 47
DESMOPRESSIN ACETATE 50 50 69 332
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.